vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and TRIMAS CORP (TRS). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $256.5M, roughly 1.3× TRIMAS CORP). TRIMAS CORP runs the higher net margin — 31.9% vs 4.0%, a 27.8% gap on every dollar of revenue. On growth, TRIMAS CORP posted the faster year-over-year revenue change (3.8% vs 2.2%).

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.

GRDN vs TRS — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.3× larger
GRDN
$336.6M
$256.5M
TRS
Growing faster (revenue YoY)
TRS
TRS
+1.6% gap
TRS
3.8%
2.2%
GRDN
Higher net margin
TRS
TRS
27.8% more per $
TRS
31.9%
4.0%
GRDN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GRDN
GRDN
TRS
TRS
Revenue
$336.6M
$256.5M
Net Profit
$13.5M
$81.7M
Gross Margin
22.7%
12.8%
Operating Margin
5.3%
5.7%
Net Margin
4.0%
31.9%
Revenue YoY
2.2%
3.8%
Net Profit YoY
46.1%
236.9%
EPS (diluted)
$0.21
$2.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
TRS
TRS
Q1 26
$336.6M
$256.5M
Q4 25
$397.6M
$-140.0M
Q3 25
$377.4M
$269.3M
Q2 25
$344.3M
$274.8M
Q1 25
$329.3M
$241.7M
Q4 24
$-66.2M
Q3 24
$314.4M
$229.4M
Q2 24
$240.5M
Net Profit
GRDN
GRDN
TRS
TRS
Q1 26
$13.5M
$81.7M
Q4 25
$20.9M
$81.7M
Q3 25
$9.8M
$9.3M
Q2 25
$9.0M
$16.7M
Q1 25
$9.4M
$12.4M
Q4 24
$5.6M
Q3 24
$-122.0M
$2.5M
Q2 24
$10.9M
Gross Margin
GRDN
GRDN
TRS
TRS
Q1 26
22.7%
12.8%
Q4 25
21.5%
Q3 25
19.8%
12.8%
Q2 25
19.8%
13.8%
Q1 25
19.5%
13.6%
Q4 24
Q3 24
19.4%
15.4%
Q2 24
14.4%
Operating Margin
GRDN
GRDN
TRS
TRS
Q1 26
5.3%
5.7%
Q4 25
7.7%
Q3 25
4.3%
6.2%
Q2 25
3.7%
9.9%
Q1 25
3.9%
9.0%
Q4 24
Q3 24
-33.3%
3.6%
Q2 24
7.4%
Net Margin
GRDN
GRDN
TRS
TRS
Q1 26
4.0%
31.9%
Q4 25
5.3%
-58.4%
Q3 25
2.6%
3.5%
Q2 25
2.6%
6.1%
Q1 25
2.9%
5.1%
Q4 24
-8.5%
Q3 24
-38.8%
1.1%
Q2 24
4.5%
EPS (diluted)
GRDN
GRDN
TRS
TRS
Q1 26
$0.21
$2.03
Q4 25
$2.01
Q3 25
$0.23
Q2 25
$0.41
Q1 25
$0.30
Q4 24
$0.14
Q3 24
$0.06
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
TRS
TRS
Cash + ST InvestmentsLiquidity on hand
$64.9M
$30.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$232.4M
$705.6M
Total Assets
$426.9M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
TRS
TRS
Q1 26
$64.9M
$30.0M
Q4 25
$65.6M
$30.0M
Q3 25
$36.5M
$33.6M
Q2 25
$18.8M
$30.3M
Q1 25
$14.0M
$32.7M
Q4 24
$23.1M
Q3 24
$37.2M
$26.9M
Q2 24
$35.0M
Total Debt
GRDN
GRDN
TRS
TRS
Q1 26
Q4 25
$0
$469.2M
Q3 25
$407.1M
Q2 25
$424.5M
Q1 25
$434.2M
Q4 24
$398.1M
Q3 24
$34.3M
$409.9M
Q2 24
$427.4M
Stockholders' Equity
GRDN
GRDN
TRS
TRS
Q1 26
$232.4M
$705.6M
Q4 25
$217.9M
$705.6M
Q3 25
$195.5M
$725.0M
Q2 25
$179.7M
$715.3M
Q1 25
$163.2M
$686.6M
Q4 24
$667.3M
Q3 24
$133.9M
$682.8M
Q2 24
$675.9M
Total Assets
GRDN
GRDN
TRS
TRS
Q1 26
$426.9M
$1.5B
Q4 25
$412.7M
$1.5B
Q3 25
$390.0M
$1.4B
Q2 25
$356.3M
$1.4B
Q1 25
$334.0M
$1.4B
Q4 24
$1.3B
Q3 24
$348.0M
$1.4B
Q2 24
$1.4B
Debt / Equity
GRDN
GRDN
TRS
TRS
Q1 26
Q4 25
0.00×
0.66×
Q3 25
0.56×
Q2 25
0.59×
Q1 25
0.63×
Q4 24
0.60×
Q3 24
0.26×
0.60×
Q2 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
TRS
TRS
Operating Cash FlowLast quarter
$6.1M
$117.5M
Free Cash FlowOCF − Capex
$36.8M
FCF MarginFCF / Revenue
14.4%
Capex IntensityCapex / Revenue
18.9%
Cash ConversionOCF / Net Profit
0.45×
1.44×
TTM Free Cash FlowTrailing 4 quarters
$109.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
TRS
TRS
Q1 26
$6.1M
$117.5M
Q4 25
$34.6M
$41.5M
Q3 25
$28.2M
$36.5M
Q2 25
$19.9M
$30.3M
Q1 25
$17.6M
$9.2M
Q4 24
$27.1M
Q3 24
$22.0M
Q2 24
$18.4M
Free Cash Flow
GRDN
GRDN
TRS
TRS
Q1 26
$36.8M
Q4 25
$36.8M
Q3 25
$24.2M
$22.8M
Q2 25
$13.2M
Q1 25
$-3.8M
Q4 24
$12.1M
Q3 24
$10.2M
Q2 24
$7.5M
FCF Margin
GRDN
GRDN
TRS
TRS
Q1 26
14.4%
Q4 25
-26.3%
Q3 25
6.4%
8.5%
Q2 25
4.8%
Q1 25
-1.6%
Q4 24
-18.3%
Q3 24
4.4%
Q2 24
3.1%
Capex Intensity
GRDN
GRDN
TRS
TRS
Q1 26
18.9%
Q4 25
-3.4%
Q3 25
1.1%
5.1%
Q2 25
6.2%
Q1 25
5.4%
Q4 24
-22.6%
Q3 24
5.2%
Q2 24
4.5%
Cash Conversion
GRDN
GRDN
TRS
TRS
Q1 26
0.45×
1.44×
Q4 25
1.65×
0.51×
Q3 25
2.87×
3.92×
Q2 25
2.21×
1.81×
Q1 25
1.86×
0.74×
Q4 24
4.80×
Q3 24
8.71×
Q2 24
1.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons